Home > National Drug Code (NDC) > Pioglitazone

Pioglitazone - 51079-513-20 - (pioglitazone)

Alphabetical Index


Drug Information of Pioglitazone

Product NDC: 51079-513
Proprietary Name: Pioglitazone
Non Proprietary Name: pioglitazone
Active Ingredient(s): 15    mg/1 & nbsp;   pioglitazone
Administration Route(s): ORAL
Dosage Form(s): TABLET
Coding System: National Drug Codes(NDC)

Labeler Information of Pioglitazone

Product NDC: 51079-513
Labeler Name: Mylan Institutional Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA076801
Marketing Category: ANDA
Start Marketing Date: 20120907

Package Information of Pioglitazone

Package NDC: 51079-513-20
Package Description: 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-513-20) > 1 TABLET in 1 BLISTER PACK (51079-513-01)

NDC Information of Pioglitazone

NDC Code 51079-513-20
Proprietary Name Pioglitazone
Package Description 100 BLISTER PACK in 1 BOX, UNIT-DOSE (51079-513-20) > 1 TABLET in 1 BLISTER PACK (51079-513-01)
Product NDC 51079-513
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name pioglitazone
Dosage Form Name TABLET
Route Name ORAL
Start Marketing Date 20120907
Marketing Category Name ANDA
Labeler Name Mylan Institutional Inc.
Substance Name PIOGLITAZONE HYDROCHLORIDE
Strength Number 15
Strength Unit mg/1
Pharmaceutical Classes Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC],Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [Chemical/Ingredient],PPAR gamma [Chemical/Ingredient],Thiazolidinedione [EPC],Thiazolidinediones [Chemical/Ingredient]

Complete Information of Pioglitazone


General Information